EverHint – EMA10 × Price × MACD – Top 10 Buy Signals for Mar 02, 2026

What This Signal Is (Quick)

This is an experimental strategy that combines two bullish signals occurring on the same day:

1. Price crosses above EMA10 from below

   • Yesterday: price_prev <= ema10_prev
   • Today: price > ema10
   • Indicates price breaking above short-term trend

2. MACD Line crosses above Signal Line from below

   • Yesterday: macd_line_prev <= macd_signal_prev
   • Today: macd_line > macd_signal
   • Confirms bullish momentum shift

Double Confirmation: Both crossovers must happen simultaneously on the signal date, providing higher-quality setups with stronger conviction.

Key Characteristics:

• Buy signals only - This strategy generates only bullish signals (no sell signals)
• Fewer but higher quality - Dual confirmation means 5-20 signals per day vs. 20-40 for single-indicator strategies
• Fast response - EMA10 catches early momentum shifts
• Momentum context - MACD adds underlying momentum confirmation
• Swing trading focus - Ideal for 1-4 week holding periods

Key Criteria:

• Buy: Price > EMA10 AND MACD line crosses above signal line

• Sell: Price < EMA10 AND MACD line crosses below signal line

• Minimum ADV: $40M (liquidity filter)

• Earnings buffer: 7 days pre/post earnings

• Fresh signal: All conditions met on today's close

Holding Period: 1-3 weeks
Risk Level: Medium-High

How We Ranked Today

Ranked by RSI (lower RSI = more oversold for buy signals)

📈 Buy-Side Signals (Top 10 of 12 total)

Ranked by RSI (lower RSI = more oversold for buy signals):

📉 Sell-Side Signals (0 Total)

Ranked by RSI (lower RSI = more oversold for buy signals):

No signals found.

Field Notes

Sector concentration: Technology (4), Industrials (3), Healthcare (2)

Insider selling: ADMA (ADMA Biologics Inc, $-215K), AMPX (Amprius Technologies, Inc., $-12.4M)

Near-term earnings: ADMA (ADMA Biologics Inc) report within 7 days. Higher volatility risk.

Data coverage: 16.7% insider, 0.0% congressional, 91.7% earnings, 100.0% analyst, 33.3% news

Peer Analysis

Understanding how these stocks relate to their industry peers:

QTWO (Q2 Holdings, Inc.): Leads 7 peers: COMP ($10.06, +3.2%), ZETA ($17.38, +2.5%), GBTG ($5.56, +1.6%), AGYS ($73.50, +1.8%), BL ($36.01, +2.2%) | Peer of: VIAV ($35.35, +19.0%), ZETA ($17.38, +2.5%)

ADMA (ADMA Biologics Inc): Leads 10 peers: ACAD ($22.81, -7.1%), PRAX ($330.59, -1.8%), BLTE ($177.58, -6.7%), LGND ($202.55, +2.1%), SLNO ($39.06, -0.0%) | Peer of: ACAD ($22.81, -7.1%), BLTE ($177.58, -6.7%), INDV ($31.98, -2.3%) and 5 more

AMPX (Amprius Technologies, Inc.): Leads 8 peers: MVST ($2.19, -2.2%), ENR ($20.50, -5.0%), ENVX ($5.45, +3.4%), KMT ($41.01, +1.8%), NSP ($21.13, -4.9%) | Peer of: ATKR ($65.41, +1.1%), ATRO ($81.35, +0.9%), EAF ($7.22, +3.9%) and 8 more

MIR (Mirion Technologies, Inc.): Leads 9 peers: JBTM ($154.39, +0.2%), MIDD ($164.99, -2.3%), GTES ($27.60, +0.1%), MOG-A ($345.27, +2.3%), NPO ($264.05, +2.1%) | Peer of: GTLS ($207.06, -0.1%), MIDD ($164.99, -2.3%)

GBDC (Golub Capital BDC, Inc.): Leads 9 peers: FHI ($56.97, +1.7%), HTGC ($14.60, +2.7%), FSK ($10.85, +0.5%), VCTR ($69.00, -0.3%), AB ($39.13, -0.4%) | Peer of: AB ($39.13, -0.4%), AGO ($87.45, +1.4%), APAM ($40.42, +0.3%) and 11 more

CLF (Cleveland-Cliffs Inc.): Leads 10 peers: GGB ($3.98, -1.5%), TX ($43.40, -0.2%), CMC ($73.60, +0.4%), EMN ($75.28, -0.3%), BTG ($6.01, -2.4%) | Peer of: AG ($31.60, -1.3%), BTG ($6.01, -2.4%), BVN ($42.82, -1.9%) and 7 more

EXTR (Extreme Networks, Inc.): Leads 9 peers: ONDS ($10.67, +5.8%), KN ($27.60, +1.6%), DIOD ($72.10, +5.7%), ODD ($12.31, +4.6%), CNXC ($31.77, -3.1%) | Peer of: ONDS ($10.67, +5.8%), VIAV ($35.35, +19.0%)

GMAB (Genmab A/S): Leads 10 peers: INCY ($100.04, -1.2%), UTHR ($513.82, +2.0%), RPRX ($47.47, +2.7%), THC ($235.12, -1.8%), ILMN ($132.89, -1.2%) | Peer of: BIIB ($188.05, -2.0%), BNTX ($107.48, -2.5%), CNC ($44.60, -0.6%) and 5 more

BL (BlackLine, Inc.): Leads 9 peers: DAVE ($199.01, +3.0%), AGYS ($73.50, +1.8%), ASAN ($7.30, +2.8%), GBTG ($5.56, +1.6%), VERX ($14.40, -0.6%) | Peer of: AGYS ($73.50, +1.8%), DAVE ($199.01, +3.0%), DOCN ($58.24, +3.9%) and 7 more

LOPE (Grand Canyon Education, Inc.): Leads 8 peers: LRN ($85.98, +1.9%), TAL ($10.56, +0.3%), LAUR ($32.39, +0.1%), POST ($106.65, +0.3%), GHC ($1049.19, -0.4%) | Peer of: AKO-B ($27.75, -2.8%), EDU ($54.64, -0.0%), ELF ($81.64, -11.3%) and 4 more

Recent Headlines

ADMA (ADMA Biologics Inc)

• ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative (source)
• ADMA Q4 EPS Up 14% Y/Y, Revenues Gain From Strong Asceniv Performance (source)
• ADMA Biologics, Inc. (ADMA) Q4 2025 Earnings Call Transcript (source)
• ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update (source)

AMPX (Amprius Technologies, Inc.)

• 5 Hot Buys Ready to Spring Higher in March (source)
• Counterpoint Mutual Funds LLC Purchases Shares of 47,639 Amprius Technologies, Inc. $AMPX (source)

BL (BlackLine, Inc.)

• MGNI vs. BL: Which Stock Is the Better Value Option? (source)
• BlackLine Stock Down Nearly 30% as One Fund Cuts Stake by $10 Million (source)
• BlackLine Honors 2025 Partner Award Winners (source)
• BlackLine Announces Participation in Upcoming Investor Conferences (source)

CLF (Cleveland-Cliffs Inc.)

• After A Tough 2025, What's Next For CLF Stock? (source)
• Vale vs. Cleveland-Cliffs: Which Stock is a Better Buy Now? (source)
• Cleveland-Cliffs Inc. Appoints Ralph Michael as Lead Director (source)

Market Context

The broader market exhibited solid gains on the session, with the S&P 500 up 0.84%, Nasdaq advancing 1.87%, and Dow Jones rising 0.21%, signaling a risk-on environment supportive of momentum strategies like EMA10 price MACD. This upward trend direction enhances the reliability of such signals, as sustained buying pressure aligns with the strategy's focus on short-term exponential moving average crossovers and MACD momentum confirmation, particularly amid 12 total signals.

Declining volatility, evidenced by the VIX dropping 13.06% to 21.44, reduces intraday swings and market noise, creating favorable conditions for these trend-following indicators to generate cleaner entries and exits without excessive whipsaws. Lower VIX levels temper false signals, allowing traders to capitalize on smoother price action in a bullish backdrop.

Sector dynamics show strength concentrated in technology as the top-performing area, with Nasdaq's outsized 1.87% gain highlighting rotation toward growth-oriented sectors. This implies elevated signal efficacy within technology, where EMA10 and MACD thrive on persistent uptrends, while caution applies to lagging areas like those tracked by the Dow amid uneven breadth.

Vlad's Take (EverHint)

Today's signals: Strong sector concentration in Technology (4 signals) suggests sector-specific rotation. Average RSI of 42 indicates oversold conditions.

Sharing Call-to-Action

🚀 Support the project by liking, sharing, or subscribing — it helps more readers discover these signals.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/